Karius news

Karius is a biotech company that has been making headlines recently due to its innovative approach to diagnosing infectious diseases. Here are some recent news updates about Karius:

  1. Karius raises $120 million in Series C funding: In October 2020, Karius announced that it had raised $120 million in a Series C funding round, led by investors such as ARCH Venture Partners, Foresite Capital, and Perceptive Advisors. This funding will be used to further develop the company's technology and expand its commercial operations.
  2. Karius launches new COVID-19 test: In August 2020, Karius launched a new COVID-19 test that uses its proprietary technology to detect the virus in a single blood sample. The test has been shown to be highly accurate and has the potential to be used in a variety of settings, including hospitals, clinics, and research institutions.
  3. Karius partners with Mayo Clinic: In July 2020, Karius announced a partnership with the Mayo Clinic to develop new tests for infectious diseases. The partnership will focus on developing tests for diseases such as tuberculosis, malaria, and sepsis, and will leverage the expertise of both organizations.
  4. Karius expands its leadership team: In June 2020, Karius announced the appointment of several new leaders to its team, including a new Chief Medical Officer and a new Vice President of Research and Development. These appointments are expected to help drive the company's growth and innovation.
  5. Karius receives FDA clearance for its Lyme disease test: In May 2020, Karius announced that it had received FDA clearance for its Lyme disease test, which uses its proprietary technology to detect the bacteria that causes the disease. The test is expected to be used in a variety of settings, including hospitals, clinics, and research institutions.

These are just a few examples of the recent news updates about Karius. The company is making significant progress in the development of its technology and is poised to make a significant impact in the field of infectious disease diagnosis.